/https://pbcdn1.podbean.com/imglogo/image-logo/14988821/NEJM_AIGR_ID_RGB-3000.jpg)
NEJM AI Grand Rounds
NEJM Group
Weave’s Brandon Rice on Rebuilding Drug Regulation with AI
JUL 15, 202645 MIN
/https://pbcdn1.podbean.com/imglogo/image-logo/14988821/NEJM_AIGR_ID_RGB-3000.jpg)
Description
Brandon Rice believes that improving health care sometimes means improving the systems behind it. Through his work at Weave, he focuses on modernizing the regulatory infrastructure that helps bring new medicines to market. He discusses the challenge of organizing scientific knowledge, communicating with regulators, and navigating processes that can span more than a decade. His vision is that AI can reduce administrative burden while preserving the rigor required for patient safety and scientific progress.
Transcript.

